|
| Exchange Received Time 26/07/2018 14:41:12 Exchange Disseminated Time 26/07/2018 14:41:18 Time Taken 00:00:06 |
We refer to our letter dated June 27, 2018, informing you about the Board Meeting of Novartis India Limited that was scheduled for today. Please note that the Board of Directors of the Company met today at 11.00 a.m. and the meeting concluded at 02.30 p.m.
The following items were considered and approved:
1. Financial results for the quarter ended June 30, 2018 along with the Limited Review Report provided by M/s, Deloitte Haskins & Sells LLP, Statutory Auditors of the Company.
2. Change in the registered office of the Company within local limits of Mumbai, from existing premises of Sandoz House, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 018 to The Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai - 400 051 effective August 6, 2018, onwards.
We have made arrangements for publishing an extract of the above mentioned financial results as per the format prescribed under Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements),
|
|
|